CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance.

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance.

Item
http://www.wikidata.org/entity/Q33569009
High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancerCurrent role of image-guided robotic radiosurgery (Cyberknife(®) ) for prostate cancer treatmentIs robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected].Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsTreating adrenal tumors in 26 patients with CyberKnife: a mono-institutional experienceStereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma.Radiation treatment for patients with intermediate-risk prostate cancer.Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.Image-guided radiation therapy for muscle-invasive bladder cancer.Clinical Outcomes of CyberKnife Radiotherapy in Prostate Cancer Patients: Short-term, Single-Center ExperienceUse, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes.Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife.An online x-ray based position validation system for prostate hypofractionated radiotherapy.
P2860

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance.

Item
http://www.wikidata.org/entity/Q33569009
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@ast
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@en
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@nl
type
label
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@ast
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@en
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@nl
prefLabel
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@ast
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@en
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
CyberKnife stereotactic radiot ...... e, feasibility, and tolerance.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921